scholarly journals Towards functional regeneration of perhaps the most difficult tissue in the body: articular cartilage

2019 ◽  
Vol 37 (3) ◽  
pp. 11-12
Author(s):  
P. R. Van Weeren

Regenerative medicine aims at restoring or improving lost or affected functions of the body by stimulating the inherent healing capacity of tissues. The central paradigm of tissue engineering is that such repair is facilitated and enhanced using several approaches that may range from application of biologically active products (such as growth factor containing platelet rich plasma (PRP) or stem cells from a variety of sources) to the use of biofabricated implants. In all cases the aim is that in the end the body’s own healing capacity will result in the production of tissues that are identical to or at least functionally equivalent to the original tissues of which the function has been (partially) lost. In the case of the use of biofabricated implants, these are meant as temporary scaffolds that will stimulate the body’s own cells through a variety of cues but are destined to finally degrade and be replaced by newly made tissue. Ideally, this is a well-balanced gradual process in which there is a match between the disappearance (and loss of biological effect) of the engineered tissues and the formation (and increased biological effect) of the native tissues that replace the implant.There are many examples of successful applications of this theory, e.g. in the areas of bladder reconstruction (Londono & Badylak 2015). However, recently, it has become clear that this concept (and hence the paradigm) does not hold for articular cartilage because the collagen network, which is crucial for the biomechanical functions of articular cartilage, will, once damaged, not be reconstituted to any degree in mature individuals (Heinemeier et al. 2016). For this reason, a paradigm shift is necessary in the field of regenerative medicine of articular cartilage and attempts at tissue engineering in this field will have to be redirected. There are in principle two ways to achieve such a paradigm shift: either by recreating the tissue homeostatic and (epi)genetic environment as present in fetuses and young, growing, individuals in which remodeling of the collagen network is still possible, or by adopting Nature’s approach in the mature individual, i.e. by creating a life-long persisting, immutable structural component of articular cartilage. Both ways face considerable challenges before they can become reality.

2021 ◽  
Author(s):  
Duarte Nuno Carvalho ◽  
Rui Reis ◽  
T. H. Silva

The body´s self-repair capacity is limited, including injuries on articular cartilage zones. Over the past few decades, tissue engineering and regenerative medicine (TERM) have focused the studies on the development...


2014 ◽  
Vol 26 (19) ◽  
pp. 3024-3034 ◽  
Author(s):  
Abhigyan Satyam ◽  
Pramod Kumar ◽  
Xingliang Fan ◽  
Alexander Gorelov ◽  
Yury Rochev ◽  
...  

2018 ◽  
Vol 18 (3) ◽  
pp. 264 ◽  
Author(s):  
Roberto Berebichez-Fridman ◽  
Pablo R. Montero-Olvera

First discovered by Friedenstein in 1976, mesenchymal stem cells (MSCs) are adult stem cells found throughout the body that share a fixed set of characteristics. Discovered initially in the bone marrow, this cell source is considered the gold standard for clinical research, although various other sources—including adipose tissue, dental pulp, mobilised peripheral blood and birth-derived tissues—have since been identified. Although similar, MSCs derived from different sources possess distinct characteristics, advantages and disadvantages, including their differentiation potential and proliferation capacity, which influence their applicability. Hence, they may be used for specific clinical applications in the fields of regenerative medicine and tissue engineering. This review article summarises current knowledge regarding the various sources, characteristics and therapeutic applications of MSCs.Keywords: Mesenchymal Stem Cells; Adult Stem Cells; Regenerative Medicine; Cell Differentiation; Tissue Engineering.


2010 ◽  
Vol 222 (1) ◽  
pp. 23-32 ◽  
Author(s):  
Stephen M. Richardson ◽  
Judith A. Hoyland ◽  
Reza Mobasheri ◽  
Constanze Csaki ◽  
Mehdi Shakibaei ◽  
...  

2019 ◽  
Vol 8 ◽  
pp. 1483
Author(s):  
Zahra Abpeikar ◽  
Mostafa Soleimannejad ◽  
Akram Alizadeh

Osteoarthritis is one of the most common chronic diseases, which have involved 250 million people around the world. One of the challenges in the field of cartilage tissue engineering is to provide an adequate source of chondrocytes to prevent changes in gene expression profile as a result of multiple passages.We hypothesized that by creating a low invasive lesion by scalpel or shear laser in the outer ear cartilage and stimulation of wound healing process, hyperplasia occurs and will provide an appropriate number of autologous chondrocytes for extraction and use in articular cartilage tissue engineering. Also, due to the effect of platelet-rich plasma and biomechanical forces in stimulating and accelerating of the repair process, these two factors can be used to achieve more desirable results.We describe a new approach to proliferate chondrocytes in the body. To evaluate this idea, various techniques of gene expression at the level of RNA or protein and animal experiments for histological studies can be used. Also, flowcytometry technique can be used to determine the cell viability and counting them.The use of autologous cell sources with minimal changes in gene expression profile can be promising in tissue engineering products. [GMJ.2019;8:e1483]


Cells ◽  
2020 ◽  
Vol 9 (9) ◽  
pp. 2094
Author(s):  
Yunqing Kang

Biomaterials play a key role in modern tissue engineering and regenerative medicine. They are expected to take over the function of a damaged tissue in the long term, trigger the self-healing potential of the body, and biodegrade at an appropriate rate. To meet these requirements, it is imperative to understand the cell-biomaterial interactions and develop new cell biotechnologies. The collection of this Special Issue brings together a number of studies portraying the underlying mechanisms of cell-biomaterial interactions.


2019 ◽  
Author(s):  
Dominic Henn ◽  
Kellen Chen ◽  
Janos A. Barrera ◽  
Jagannath Padmanabhan ◽  
Sun Hyung Kwon ◽  
...  

Grafting is defined as a surgical procedure in which tissue is transplanted without its native blood supply from one anatomic region of the body to another. A graft can be transplanted within the same individual (autograft), or between individuals of the same (allograft) or a different species (xenograft). A graft fully relies on the blood supply of its recipient site, which is why healthy and well vascularized recipient sites are prerequisites for successful graft healing. Various types of tissues can be grafted with reliable healing rates and have become part of standard surgical treatment strategies. Pre-clinical research approaches within tissue engineering and regenerative medicine using stem cells, biological scaffolds, biomolecules, and gene therapy have demonstrated great advances in graft vascularization and healing and may yield translational treatment strategies improving patient outcomes in the future. This review contains 3 figures, and 48 references. Keywords: autograft, allograft, xenograft, vascularization, skin grafting, fat grafting, tissue engineering, regenerative medicine


Sign in / Sign up

Export Citation Format

Share Document